Shanghai Badi Biopharmaceutical Technology Co., Ltd. is a high-tech enterprise integrating research, production, and operation, primarily dedicated to the research, development, and production of carbapenem series penem antibiotic raw materials and intermediates. After several years of rapid development, the company has gradually formed a development strategy focused on chiral chemical synthesis, aiming at the research, development, and production of pharmaceutical intermediates. The company possesses strong independent development capabilities, with a robust R&D team and a domestically leading chiral chemical laboratory. It has also established well-equipped pilot and production bases, and has currently achieved the industrial production of a series of products including meropenem and imipenem.